Prostate Cancer Nuclear Medicine Diagnostics Market 2027 by Type, PET Product, Geography | The Insight Partners

Prostate Cancer Nuclear Medicine Diagnostics Market Forecast to 2027 - Covid-19 Impact and Global Analysis - by Type (SPECT, PET); PET Product (F-18, C11, GA 68 PSMA), and Geography

Report Code: TIPRE00009519 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid

MARKET INTRODUCTION

Prostate cancer is cancer affecting the prostate glands in men. Prostate cancer is the second most common cancer after skin cancer in men. Several common factors accountable for the onset of prostate cancer are old age, family history, and race. Nuclear medicine is imaging that requires radioactive materials. It is a useful method to detect and also treat prostate cancer and helps radiologists to conclude the stage of cancer.

MARKET DYNAMICS

The prostate cancer nuclear medicine diagnostics market is projected to grow in the forecast period owing to the increasing incidence of prostate cancer and the presence of reimbursement policies. Moreover, increasing research activities for the development of innovative imaging agents and rising demand for early and precise diagnosis of the disease is also offering opportunities in market growth during the forecast period.

MARKET SCOPE

The “Global Prostate Cancer Nuclear Medicine Diagnostics Market Analysis to 2027” is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of prostate cancer nuclear medicine diagnostics market with detailed market segmentation by type, PET product and geography. The global prostate cancer nuclear medicine diagnostics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading prostate cancer nuclear medicine diagnostics market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global prostate cancer nuclear medicine diagnostics market is segmented on the basis of type and PET product. Based on type, the market is segmented into SPECT and PET. Based on PET product, the prostate cancer nuclear medicine diagnostics market is segmented into F-18, C11, and GA 68 PSMA.
 
REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global prostate cancer nuclear medicine diagnostics market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The prostate cancer nuclear medicine diagnostics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting prostate cancer nuclear medicine diagnostics market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the prostate cancer nuclear medicine diagnostics market in these regions.
 



Get more information on this report :

MARKET PLAYERS

The report covers key developments in the prostate cancer nuclear medicine diagnostics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from prostate cancer nuclear medicine diagnostics market are anticipated to lucrative growth opportunities in the future with the rising demand for prostate cancer nuclear medicine diagnostics in the global market. Below mentioned is the list of few companies engaged in the prostate cancer nuclear medicine diagnostics market.

The report also includes the profiles of key prostate cancer nuclear medicine diagnostics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  • Blue Earth Diagnostics Limited
  • Progenics Pharmaceuticals, Inc.
  • Theradiagnostics Ltd
  • Curium Pharma
  • UCSF
  • Jubilant Pharma Limited (Triad Isotopes, Inc.)
  • NCM-USA LLC
  • TELIX
  • ABX
  • Novartis AG (Endocyte)

The Insight Partner’s dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
 

 



Get more information on this report :

1.        INTRODUCTION

            1.1.       SCOPE OF THE STUDY

            1.2.       THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE

            1.3.       MARKET SEGMENTATION

                         1.3.1   Prostate Cancer Nuclear Medicine Diagnostics Market - By Type

                         1.3.2   Prostate Cancer Nuclear Medicine Diagnostics Market - By PET Product

                         1.3.3   Prostate Cancer Nuclear Medicine Diagnostics Market - By Region

                                     1.3.3.1   By Country

2.        KEY TAKEAWAYS

3.        RESEARCH METHODOLOGY

4.        PROSTATE CANCER NUCLEAR MEDICINE DIAGNOSTICS MARKET LANDSCAPE

            4.1.       OVERVIEW

            4.2.       PEST ANALYSIS

                         4.2.1        North America - Pest Analysis

                         4.2.2        Europe - Pest Analysis

                         4.2.3        Asia-Pacific - Pest Analysis

                         4.2.4        Middle East and Africa - Pest Analysis

                         4.2.5        South and Central America - Pest Analysis

            4.3.       EXPERT OPINIONS

5.        PROSTATE CANCER NUCLEAR MEDICINE DIAGNOSTICS MARKET - KEY MARKET DYNAMICS

            5.1.       KEY MARKET DRIVERS

            5.2.       KEY MARKET RESTRAINTS

            5.3.       KEY MARKET OPPORTUNITIES

            5.4.       FUTURE TRENDS

            5.5.       IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC

6.        PROSTATE CANCER NUCLEAR MEDICINE DIAGNOSTICS MARKET - GLOBAL MARKET ANALYSIS

            6.1.       PROSTATE CANCER NUCLEAR MEDICINE DIAGNOSTICS - GLOBAL MARKET OVERVIEW

            6.2.       PROSTATE CANCER NUCLEAR MEDICINE DIAGNOSTICS - GLOBAL MARKET AND FORECAST TO 2027

            6.3.       MARKET POSITIONING/MARKET SHARE

7.        PROSTATE CANCER NUCLEAR MEDICINE DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2027 – TYPE

            7.1.       OVERVIEW

            7.2.       TYPE MARKET FORECASTS AND ANALYSIS

            7.3.       SPECT

                          7.3.1.         Overview

                          7.3.2.         SPECT Market Forecast and Analysis

            7.4.       PET

                          7.4.1.         Overview

                          7.4.2.         PET Market Forecast and Analysis

8.        PROSTATE CANCER NUCLEAR MEDICINE DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2027 – PET PRODUCT

            8.1.       OVERVIEW

            8.2.       PET PRODUCT MARKET FORECASTS AND ANALYSIS

            8.3.       F-18

                          8.3.1.         Overview

                          8.3.2.         F-18 Market Forecast and Analysis

            8.4.       C11

                          8.4.1.         Overview

                          8.4.2.         C11 Market Forecast and Analysis

            8.5.       GA 68 PSMA

                          8.5.1.         Overview

                          8.5.2.         GA 68 PSMA Market Forecast and Analysis

9.        PROSTATE CANCER NUCLEAR MEDICINE DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2027 – GEOGRAPHICAL ANALYSIS

            9.1.       NORTH AMERICA

                           9.1.1      North America Prostate Cancer Nuclear Medicine Diagnostics Market Overview

                           9.1.2      North America Prostate Cancer Nuclear Medicine Diagnostics Market Forecasts and Analysis

                           9.1.3      North America Prostate Cancer Nuclear Medicine Diagnostics Market Forecasts and Analysis - By Type

                           9.1.4      North America Prostate Cancer Nuclear Medicine Diagnostics Market Forecasts and Analysis - By PET Product

                           9.1.5      North America Prostate Cancer Nuclear Medicine Diagnostics Market Forecasts and Analysis - By Countries

                                          9.1.5.1     United States Prostate Cancer Nuclear Medicine Diagnostics Market

                                                             9.1.5.1.1      United States Prostate Cancer Nuclear Medicine Diagnostics Market by Type

                                                             9.1.5.1.2      United States Prostate Cancer Nuclear Medicine Diagnostics Market by PET Product

                                          9.1.5.2     Canada Prostate Cancer Nuclear Medicine Diagnostics Market

                                                             9.1.5.2.1      Canada Prostate Cancer Nuclear Medicine Diagnostics Market by Type

                                                             9.1.5.2.2      Canada Prostate Cancer Nuclear Medicine Diagnostics Market by PET Product

                                          9.1.5.3     Mexico Prostate Cancer Nuclear Medicine Diagnostics Market

                                                             9.1.5.3.1      Mexico Prostate Cancer Nuclear Medicine Diagnostics Market by Type

                                                             9.1.5.3.2      Mexico Prostate Cancer Nuclear Medicine Diagnostics Market by PET Product

            9.2.       EUROPE

                           9.2.1      Europe Prostate Cancer Nuclear Medicine Diagnostics Market Overview

                           9.2.2      Europe Prostate Cancer Nuclear Medicine Diagnostics Market Forecasts and Analysis

                           9.2.3      Europe Prostate Cancer Nuclear Medicine Diagnostics Market Forecasts and Analysis - By Type

                           9.2.4      Europe Prostate Cancer Nuclear Medicine Diagnostics Market Forecasts and Analysis - By PET Product

                           9.2.5      Europe Prostate Cancer Nuclear Medicine Diagnostics Market Forecasts and Analysis - By Countries

                                          9.2.5.1     Germany Prostate Cancer Nuclear Medicine Diagnostics Market

                                                             9.2.5.1.1      Germany Prostate Cancer Nuclear Medicine Diagnostics Market by Type

                                                             9.2.5.1.2      Germany Prostate Cancer Nuclear Medicine Diagnostics Market by PET Product

                                          9.2.5.2     France Prostate Cancer Nuclear Medicine Diagnostics Market

                                                             9.2.5.2.1      France Prostate Cancer Nuclear Medicine Diagnostics Market by Type

                                                             9.2.5.2.2      France Prostate Cancer Nuclear Medicine Diagnostics Market by PET Product

                                          9.2.5.3     Italy Prostate Cancer Nuclear Medicine Diagnostics Market

                                                             9.2.5.3.1      Italy Prostate Cancer Nuclear Medicine Diagnostics Market by Type

                                                             9.2.5.3.2      Italy Prostate Cancer Nuclear Medicine Diagnostics Market by PET Product

                                          9.2.5.4     Spain Prostate Cancer Nuclear Medicine Diagnostics Market

                                                             9.2.5.4.1      Spain Prostate Cancer Nuclear Medicine Diagnostics Market by Type

                                                             9.2.5.4.2      Spain Prostate Cancer Nuclear Medicine Diagnostics Market by PET Product

                                          9.2.5.5     United Kingdom Prostate Cancer Nuclear Medicine Diagnostics Market

                                                             9.2.5.5.1      United Kingdom Prostate Cancer Nuclear Medicine Diagnostics Market by Type

                                                             9.2.5.5.2      United Kingdom Prostate Cancer Nuclear Medicine Diagnostics Market by PET Product

            9.3.       ASIA-PACIFIC

                           9.3.1      Asia-Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Overview

                           9.3.2      Asia-Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Forecasts and Analysis

                           9.3.3      Asia-Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Forecasts and Analysis - By Type

                           9.3.4      Asia-Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Forecasts and Analysis - By PET Product

                           9.3.5      Asia-Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Forecasts and Analysis - By Countries

                                          9.3.5.1     Australia Prostate Cancer Nuclear Medicine Diagnostics Market

                                                             9.3.5.1.1      Australia Prostate Cancer Nuclear Medicine Diagnostics Market by Type

                                                             9.3.5.1.2      Australia Prostate Cancer Nuclear Medicine Diagnostics Market by PET Product

                                          9.3.5.2     China Prostate Cancer Nuclear Medicine Diagnostics Market

                                                             9.3.5.2.1      China Prostate Cancer Nuclear Medicine Diagnostics Market by Type

                                                             9.3.5.2.2      China Prostate Cancer Nuclear Medicine Diagnostics Market by PET Product

                                          9.3.5.3     India Prostate Cancer Nuclear Medicine Diagnostics Market

                                                             9.3.5.3.1      India Prostate Cancer Nuclear Medicine Diagnostics Market by Type

                                                             9.3.5.3.2      India Prostate Cancer Nuclear Medicine Diagnostics Market by PET Product

                                          9.3.5.4     Japan Prostate Cancer Nuclear Medicine Diagnostics Market

                                                             9.3.5.4.1      Japan Prostate Cancer Nuclear Medicine Diagnostics Market by Type

                                                             9.3.5.4.2      Japan Prostate Cancer Nuclear Medicine Diagnostics Market by PET Product

                                          9.3.5.5     South Korea Prostate Cancer Nuclear Medicine Diagnostics Market

                                                             9.3.5.5.1      South Korea Prostate Cancer Nuclear Medicine Diagnostics Market by Type

                                                             9.3.5.5.2      South Korea Prostate Cancer Nuclear Medicine Diagnostics Market by PET Product

            9.4.       MIDDLE EAST AND AFRICA

                           9.4.1      Middle East and Africa Prostate Cancer Nuclear Medicine Diagnostics Market Overview

                           9.4.2      Middle East and Africa Prostate Cancer Nuclear Medicine Diagnostics Market Forecasts and Analysis

                           9.4.3      Middle East and Africa Prostate Cancer Nuclear Medicine Diagnostics Market Forecasts and Analysis - By Type

                           9.4.4      Middle East and Africa Prostate Cancer Nuclear Medicine Diagnostics Market Forecasts and Analysis - By PET Product

                           9.4.5      Middle East and Africa Prostate Cancer Nuclear Medicine Diagnostics Market Forecasts and Analysis - By Countries

                                          9.4.5.1     South Africa Prostate Cancer Nuclear Medicine Diagnostics Market

                                                             9.4.5.1.1      South Africa Prostate Cancer Nuclear Medicine Diagnostics Market by Type

                                                             9.4.5.1.2      South Africa Prostate Cancer Nuclear Medicine Diagnostics Market by PET Product

                                          9.4.5.2     Saudi Arabia Prostate Cancer Nuclear Medicine Diagnostics Market

                                                             9.4.5.2.1      Saudi Arabia Prostate Cancer Nuclear Medicine Diagnostics Market by Type

                                                             9.4.5.2.2      Saudi Arabia Prostate Cancer Nuclear Medicine Diagnostics Market by PET Product

                                          9.4.5.3     U.A.E Prostate Cancer Nuclear Medicine Diagnostics Market

                                                             9.4.5.3.1      U.A.E Prostate Cancer Nuclear Medicine Diagnostics Market by Type

                                                             9.4.5.3.2      U.A.E Prostate Cancer Nuclear Medicine Diagnostics Market by PET Product

            9.5.       SOUTH AND CENTRAL AMERICA

                           9.5.1      South and Central America Prostate Cancer Nuclear Medicine Diagnostics Market Overview

                           9.5.2      South and Central America Prostate Cancer Nuclear Medicine Diagnostics Market Forecasts and Analysis

                           9.5.3      South and Central America Prostate Cancer Nuclear Medicine Diagnostics Market Forecasts and Analysis - By Type

                           9.5.4      South and Central America Prostate Cancer Nuclear Medicine Diagnostics Market Forecasts and Analysis - By PET Product

                           9.5.5      South and Central America Prostate Cancer Nuclear Medicine Diagnostics Market Forecasts and Analysis - By Countries

                                          9.5.5.1     Brazil Prostate Cancer Nuclear Medicine Diagnostics Market

                                                             9.5.5.1.1      Brazil Prostate Cancer Nuclear Medicine Diagnostics Market by Type

                                                             9.5.5.1.2      Brazil Prostate Cancer Nuclear Medicine Diagnostics Market by PET Product

                                          9.5.5.2     Argentina Prostate Cancer Nuclear Medicine Diagnostics Market

                                                             9.5.5.2.1      Argentina Prostate Cancer Nuclear Medicine Diagnostics Market by Type

                                                             9.5.5.2.2      Argentina Prostate Cancer Nuclear Medicine Diagnostics Market by PET Product

10.        INDUSTRY LANDSCAPE

               10.1.       MERGERS AND ACQUISITIONS

               10.2.       AGREEMENTS, COLLABORATIONS AND JOIN VENTURES

               10.3.       NEW PRODUCT LAUNCHES

               10.4.       EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11.        PROSTATE CANCER NUCLEAR MEDICINE DIAGNOSTICS MARKET, KEY COMPANY PROFILES

               11.1.     BLUE EARTH DIAGNOSTICS LIMITED

                              11.1.1.      Key Facts

                              11.1.2.      Business Description

                              11.1.3.      Products and Services

                              11.1.4.      Financial Overview

                              11.1.5.      SWOT Analysis

                              11.1.6.      Key Developments

               11.2.     PROGENICS PHARMACEUTICALS, INC.

                              11.2.1.      Key Facts

                              11.2.2.      Business Description

                              11.2.3.      Products and Services

                              11.2.4.      Financial Overview

                              11.2.5.      SWOT Analysis

                              11.2.6.      Key Developments

               11.3.     THERADIAGNOSTICS LTD

                              11.3.1.      Key Facts

                              11.3.2.      Business Description

                              11.3.3.      Products and Services

                              11.3.4.      Financial Overview

                              11.3.5.      SWOT Analysis

                              11.3.6.      Key Developments

               11.4.     CURIUM PHARMA

                              11.4.1.      Key Facts

                              11.4.2.      Business Description

                              11.4.3.      Products and Services

                              11.4.4.      Financial Overview

                              11.4.5.      SWOT Analysis

                              11.4.6.      Key Developments

               11.5.     UCSF

                              11.5.1.      Key Facts

                              11.5.2.      Business Description

                              11.5.3.      Products and Services

                              11.5.4.      Financial Overview

                              11.5.5.      SWOT Analysis

                              11.5.6.      Key Developments

               11.6.     JUBILANT PHARMA LIMITED (TRIAD ISOTOPES, INC.)

                              11.6.1.      Key Facts

                              11.6.2.      Business Description

                              11.6.3.      Products and Services

                              11.6.4.      Financial Overview

                              11.6.5.      SWOT Analysis

                              11.6.6.      Key Developments

               11.7.     NCM-USA LLC

                              11.7.1.      Key Facts

                              11.7.2.      Business Description

                              11.7.3.      Products and Services

                              11.7.4.      Financial Overview

                              11.7.5.      SWOT Analysis

                              11.7.6.      Key Developments

               11.8.     TELIX

                              11.8.1.      Key Facts

                              11.8.2.      Business Description

                              11.8.3.      Products and Services

                              11.8.4.      Financial Overview

                              11.8.5.      SWOT Analysis

                              11.8.6.      Key Developments

               11.9.     ABX

                              11.9.1.      Key Facts

                              11.9.2.      Business Description

                              11.9.3.      Products and Services

                              11.9.4.      Financial Overview

                              11.9.5.      SWOT Analysis

                              11.9.6.      Key Developments

               11.10.     NOVARTIS AG (ENDOCYTE)

                              11.10.1.      Key Facts

                              11.10.2.      Business Description

                              11.10.3.      Products and Services

                              11.10.4.      Financial Overview

                              11.10.5.      SWOT Analysis

                              11.10.6.      Key Developments

12.        APPENDIX

               12.1.       ABOUT THE INSIGHT PARTNERS

               12.2.       GLOSSARY OF TERMS

The List of Companies - Prostate Cancer Nuclear Medicine Diagnostics Market

  1. Blue Earth Diagnostics Limited
  2. Progenics Pharmaceuticals, Inc.
  3. Theradiagnostics Ltd
  4. Curium Pharma
  5. UCSF
  6. Jubilant Pharma Limited (Triad Isotopes, Inc.)
  7. NCM-USA LLC
  8. TELIX
  9. ABX
  10. Novartis AG (Endocyte)
TIPRE00009519
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking